Inbs should I sell my stock

Selling your Intelligent Bio Solutions (INBS) stock at this time would be premature, considering the company's recent achievements and the potential for future growth. Here's why:

1. Recent Milestones and Growth Potential:
   • Intelligent Bio Solutions has installed over 1,000 Intelligent Fingerprinting Drug Screening Readers, which is a significant milestone indicating strong demand for their technology.
   • The company has seen a 26% increase in reader sales and a 65% increase in installed readers from the previous year, demonstrating growing market acceptance and adoption.
   • These achievements underscore the company's innovation in non-invasive drug testing technology and its expanding market presence.
2. Financial Performance and Market Position:
   • Despite a negative net margin and a negative return on equity, the company has shown revenue growth, with $0.82 million reported for the quarter.
   • The company's recent partnerships and the addition of major European transport and infrastructure solutions providers to its accounts suggest a robust business model.
3. Technical Analysis and Market Indicators:
   • The stock's 5-day moving average is $1.21, and the resistance level is at $1.22. This indicates a slight upward trend, which could be a sign of potential growth.
   • The Relative Strength Index (RSI) is at 54.44, which is neither overbought nor oversold, suggesting a balanced market sentiment.
   • A Moving Average Convergence Divergence (MACD) of 0.08 indicates a potential upward momentum.
4. Analyst Ratings and Price Targets:
   • Analysts have set a high price target of $12.00, which represents a substantial increase from the current price. This suggests that analysts see potential for the stock to grow in value.
   • The company's stock is currently trading below its 50-day moving average, which could be a signal to hold the stock rather than sell.
5. Market Sentiment and Short Interest:
   • There has been an increase in short interest, which could indicate a potential short-term dip in the stock price. However, this should be monitored closely, as it can also signal a buying opportunity if the short sellers are forced to cover their positions.
6. Dividend and Financial Health:
   • Intelligent Bio Solutions does not currently pay dividends. If you are considering selling for dividend income, you should be aware of this.
   • The company's financial ratios, such as the current ratio and quick ratio, are healthy, with values of 2.02 and 1.87, respectively. This suggests that the company is financially stable.

In conclusion, while there are no guarantees in the stock market, the current indicators and recent company achievements suggest that INBS has potential for growth. If you are considering selling, it might be wise to hold onto your shares and monitor the company's progress closely before making a decision.